| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Samulski RJ | |
| Monahan PE | |||
| P2860 | cites work | Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hematocrit in nonhuman primates | Q45753061 |
| In vitro packaging of an infectious recombinant adeno-associated virus 2. | Q45758631 | ||
| Recombinant adeno-associated virus for muscle directed gene therapy | Q45764433 | ||
| Gene transfer into hematopoietic progenitor cells mediated by an adeno-associated virus vector | Q45842008 | ||
| Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector | Q45855552 | ||
| Viral receptors and vector purification: new approaches for generating clinical-grade reagents | Q45857978 | ||
| Persistent expression of canine factor IX in hemophilia B canines | Q45862802 | ||
| Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. | Q45888779 | ||
| NIDDK Workshop on AAV Vectors: Gene Transfer into Quiescent Cells | Q71670224 | ||
| Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus | Q77292224 | ||
| Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model | Q24527302 | ||
| Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use. | Q33763911 | ||
| Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. | Q33781976 | ||
| Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers | Q33782809 | ||
| Recombinant human parvovirus B19 vectors: erythroid cell-specific delivery and expression of transduced genes | Q33784686 | ||
| Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination. | Q33823450 | ||
| Immune responses to adenovirus and adeno-associated virus in humans. | Q33874473 | ||
| Insertional mutagenesis of AAV2 capsid and the production of recombinant virus | Q33883772 | ||
| Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. | Q34486856 | ||
| Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector | Q35872651 | ||
| Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein | Q35943644 | ||
| Efficient expression of CFTR function with adeno-associated virus vectors that carry shortened CFTR genes | Q36287507 | ||
| Sustained correction of bleeding disorder in hemophilia B mice by gene therapy | Q36454880 | ||
| Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors | Q36734619 | ||
| High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. | Q40933793 | ||
| High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus | Q40992577 | ||
| Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. | Q41190212 | ||
| Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. | Q42609041 | ||
| Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2. | Q43567043 | ||
| Transduction and utility of the granulocyte-macrophage colony-stimulating factor gene into monocytes and dendritic cells by adeno-associated virus. | Q45744533 | ||
| Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield | Q45747699 | ||
| Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses | Q45749766 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 24-30 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | AAV vectors: is clinical success on the horizon? | |
| P478 | volume | 7 |
| Q34779805 | A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy |
| Q30483589 | A muscle-targeting peptide displayed on AAV2 improves muscle tropism on systemic delivery |
| Q45859123 | A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice |
| Q39733540 | A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector |
| Q74061391 | A novel type of bifunctional inhibitor directed against proteolytic activity and receptor/ligand interaction. Cystatin with a urokinase receptor binding site |
| Q42259507 | A slow-release fibrin matrix increases adeno-associated virus transduction of wound repair cells in vivo |
| Q40606232 | AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo |
| Q35216648 | Adeno-associated viral vectors. |
| Q45721934 | Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors |
| Q35851146 | Adeno-associated virus mediated interferon-gamma inhibits the progression of hepatic fibrosis in vitro and in vivo |
| Q24634560 | Adeno-associated virus serotype 2 induces cell-mediated immune responses directed against multiple epitopes of the capsid protein VP1 |
| Q34080580 | Adeno-associated virus vectors for gene therapy: more pros than cons? |
| Q40394484 | Adeno-associated virus-mediated bone morphogenetic protein-7 gene transfer induces C2C12 cell differentiation into osteoblast lineage cells |
| Q40683650 | Adeno-associated virus-mediated delivery of glial cell line-derived neurotrophic factor protects motor neuron-like cells from apoptosis |
| Q40631445 | Adenovirus Transduction Induces Expression of Multiple Chemokines and Chemokine Receptors in Murine β Cells and Pancreatic Islets |
| Q37766138 | Advances in gene-based therapy for heart failure |
| Q33922811 | Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin |
| Q40011728 | Bidirectional promoter interference between two widely used internal heterologous promoters in a late-generation lentiviral construct |
| Q35923467 | CNS-directed gene therapy for lysosomal storage diseases |
| Q92258204 | CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities |
| Q34409721 | Cardiac Gene Therapy |
| Q37811189 | Cardiac gene therapy with SERCA2a: From bench to bedside |
| Q34464575 | Cell surface heparan sulfate and its roles in assisting viral infections |
| Q33942996 | Challenges and opportunities for development of an AIDS vaccine |
| Q37580174 | Chapter 11: Tissue engineering of peripheral nerves |
| Q40459996 | Chemically inactivated adenoviral vectors that can efficiently transduce target cells when delivered in the form of virus-microbead conjugates. |
| Q33846672 | Chitosan Interferon-gamma Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses |
| Q36288920 | Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications |
| Q34193457 | Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain |
| Q45881194 | Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma |
| Q34866243 | Computational and experimental analysis of DNA shuffling |
| Q39686097 | Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity |
| Q40737427 | Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease |
| Q24673796 | Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors |
| Q40442421 | Effects of rAAV-CD151 and rAAV-antiCD151 on the migration of human tongue squamous carcinoma cell line Tca8113. |
| Q24527221 | Efficient replication of adeno-associated virus type 2 vectors: a cis-acting element outside of the terminal repeats and a minimal size |
| Q39748126 | Endocytosis of adeno-associated virus type 5 leads to accumulation of virus particles in the Golgi compartment |
| Q45882831 | Enhanced expression of glutamate decarboxylase 65 improves symptoms of rat parkinsonian models. |
| Q42203734 | Evaluation of adenoviral vascular endothelial growth factor-activated chitosan/hydroxyapatite scaffold for engineering vascularized bone tissue using human osteoblasts: In vitro and in vivo studies |
| Q45861357 | Evaluation of prenatal intra-amniotic LAMB3 gene delivery in a mouse model of Herlitz disease. |
| Q38848060 | Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy |
| Q44096553 | Expanding the AAV package |
| Q43982222 | Expression of BCL-2 via adeno-associated virus vectors rescues thalamic neurons after visual cortex lesion in the adult rat. |
| Q45865993 | Expression of a truncated cystic fibrosis transmembrane conductance regulator with an AAV5-pseudotyped vector in primates |
| Q39815208 | Gene Therapy for Cardiac Arrhythmias |
| Q37011673 | Gene delivery in the equine cornea: a novel therapeutic strategy |
| Q34058700 | Gene delivery to the corneal endothelium |
| Q36727410 | Gene therapy and wound healing |
| Q35791499 | Gene therapy for heart failure |
| Q45160558 | Gene therapy for hemophilia: are viral vectors really feasible? |
| Q34569410 | Gene therapy for lung neoplasms. |
| Q74319886 | Gene therapy for prostate cancer |
| Q74362616 | Gene therapy for prostate cancer |
| Q34975453 | Gene therapy for spinal applications |
| Q33959568 | Gene therapy for spine fusion |
| Q34987206 | Gene therapy for treatment of cerebral ischemia using defective recombinant adeno-associated virus vectors |
| Q36786243 | Gene therapy in the treatment of heart failure |
| Q36477718 | Gene therapy of the ischemic lower limb--Therapeutic angiogenesis. |
| Q35140784 | Gene therapy progress and prospects: gene therapy for the hemophilias |
| Q35141791 | Gene transfer as a tool to induce therapeutic vascular growth |
| Q45864725 | Gene transfer of IkappaBalpha limits infarct size in a mouse model of myocardial ischemia-reperfusion injury. |
| Q34619896 | HIV vaccine strategies |
| Q38323043 | Hypothalamic glycogen synthase kinase 3β has a central role in the regulation of food intake and glucose metabolism. |
| Q45887392 | Hypothalamic pro-opiomelanocortin gene delivery ameliorates obesity and glucose intolerance in aged rats |
| Q35085243 | Improved survival of ischemic cutaneous and musculocutaneous flaps after vascular endothelial growth factor gene transfer using adeno-associated virus vectors |
| Q40132247 | In vitro and in vivo induction of bone formation based on adeno-associated virus-mediated BMP-7 gene therapy using human adipose-derived mesenchymal stem cells |
| Q33187644 | In vitro selection of viral vectors with modified tropism: the adeno-associated virus display |
| Q44219031 | Induction of uncoupling protein 1 by central interleukin-6 gene delivery is dependent on sympathetic innervation of brown adipose tissue and underlies one mechanism of body weight reduction in rats |
| Q45874123 | Innovations in oral gene delivery: challenges and potentials. |
| Q42518623 | Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain |
| Q40812514 | Integration of adeno-associated virus 2 DNA in human MKR melanoma cells induces a peptide with oncosuppressive properties |
| Q43776054 | Intramuscular delivery of rAAV-mediated kallikrein gene reduces hypertension and prevents cardiovascular injuries in model rats |
| Q24534210 | Intramuscular viral delivery of paraplegin rescues peripheral axonopathy in a model of hereditary spastic paraplegia |
| Q35179014 | Knockdown of dopamine D₂ receptors in the nucleus accumbens core suppresses methamphetamine-induced behaviors and signal transduction in mice. |
| Q45866024 | Lentivirus-mediated gene transfer to the rat, ovine and human cornea |
| Q45703658 | Light-activated gene transduction of recombinant adeno-associated virus in human mesenchymal stem cells |
| Q50436799 | Manipulation of single-stranded DNA by using an artificial site-selective DNA cutter composed of cerium(IV)/EDTA and phosphonate-oligonucleotide conjugates. |
| Q40289262 | Membrane-associated heparan sulfate is not required for rAAV-2 infection of human respiratory epithelia |
| Q40290223 | Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes |
| Q36174173 | New vectors and strategies for cardiovascular gene therapy |
| Q39612405 | Novel transcriptional regulatory signals in the adeno-associated virus terminal repeat A/D junction element |
| Q44974380 | Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors. |
| Q43682973 | Potent inhibition of arterial intimal hyperplasia by TIMP1 gene transfer using AAV vectors |
| Q64378233 | Prostate cancer gene therapy |
| Q45735294 | Protection from experimental endotoxemia by a recombinant adeno-associated virus encoding interleukin 10. |
| Q30975099 | Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors |
| Q45886584 | Recombinant AAV vector encoding human VEGF165 enhances wound healing. |
| Q34354096 | Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives |
| Q40263910 | Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines |
| Q33554981 | Recombinant adeno-associated virus-mediated human kallikrein gene therapy protects against hypertensive target organ injuries through inhibiting cell apoptosis |
| Q45631931 | Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries |
| Q35629594 | Regional gene therapy to enhance bone repair |
| Q34757960 | Rescuing the failing heart by targeted gene transfer |
| Q40436594 | Serotype-specific replicating AAV helper constructs increase recombinant AAV type 2 vector production |
| Q44908475 | Shuttle PCR-based cloning of the infectious adeno-associated virus type 5 genome |
| Q36314232 | Site-specific DNA recombinases as instruments for genomic surgery |
| Q34554366 | Spatial and temporal organization of adeno-associated virus DNA replication in live cells |
| Q43653610 | Standard heparin, low molecular weight heparin, low molecular weight heparinoid, and recombinant hirudin differ in their ability to inhibit transduction by recombinant adeno-associated virus type 2 vectors |
| Q36223317 | Store-Operated Ca2+ Channels in Mesangial Cells Inhibit Matrix Protein Expression |
| Q34282345 | Successful transgene expression with serial doses of aerosolized rAAV2 vectors in rhesus macaques |
| Q35857358 | The SUMOylation Pathway Restricts Gene Transduction by Adeno-Associated Viruses |
| Q42818053 | The Therapeutic Role of Very Low-Density Lipoprotein Receptor Gene in Hyperlipidemia in Type 2 Diabetic Rats |
| Q34317814 | The future of human gene therapy |
| Q34079562 | Tissue engineering via local gene delivery: update and future prospects for enhancing the technology |
| Q36157063 | Tissue kallikrein reverses insulin resistance and attenuates nephropathy in diabetic rats by activation of phosphatidylinositol 3-kinase/protein kinase B and adenosine 5'-monophosphate-activated protein kinase signaling pathways |
| Q34105795 | Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model |
| Q45884333 | Transduction of human neural progenitor cells using recombinant adeno-associated viral vectors |
| Q45880272 | Treatment of murine collagen-induced arthritis by ex vivo extracellular superoxide dismutase gene transfer |
| Q46160383 | Use of the NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae as a possible cure for complex I defects in human cells |
| Q34513988 | Using salivary glands as a tissue target for gene therapeutics |
| Q37615161 | Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells). |
| Q28141424 | Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics |
| Q38655270 | Virus-Derived Peptides for Clinical Applications |
| Q80386434 | rAAV-mediated stable expression of heme oxygenase-1 in stellate cells: a new approach to attenuate liver fibrosis in rats |
Search more.